BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Regeneron to Report Third Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on November 4, 2021

  Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its third quarter 2021 financial and operating results on Thursday, November 4, 2021 , before the U.S. financial markets open.

  October 11, 2021

   · 

  2 min read
• Deals

  Rejuveron leads EUR 15.7 million Series B investment in Rejuvenate Biomed to accelerate clinical development of its sarcopenia treatment for healthy aging

  Rejuveron Life Sciences AG today announced that it will ultimately acquire a majority shareholding in Rejuvenate Biomed NV.

  October 11, 2021

   · 

  4 min read
• Immunis.AI Reports Results of a Prospective Study of its RNAseq-Based Liquid-Biopsy in Early-Stage Prostate Cancer

  Immunis.AI, Inc. today announced the publication of pivotal results from its clinical trial, Evaluation of an RNAseq-based Immunogenomic Liquid Biopsy Approach in Early-Stage Prostate Cancer, in the journal Cells.

  October 11, 2021

   · 

  3 min read